. Silencing of OXR1 expression in the PVN did not affect the OXR1 protein level in the ventromedial hypothalamus (VMH) and dorsomedial hypothalamus (DMH) in the OZRs.
Representative western blots and summary data showing that OXR1 protein levels in the VMH (A and B) and DMH (C and D) were not significantly changed in the OZRs treated with AAV-OXR1-shRNA compared with OZRs treated with the scrambled shRNA and the untreated OZRs. (n = 4 rats in each group). OZRs-SCM: OZRs treated with AAV-scrambled shRNA; OZRsshRNA: OZRs treated with AAV-OXR1-shRNA.
